EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validation of Artificial Intelligence (AI)-Assisted Flow Cytometry Analysis for Immunological Disorders

Zhengchun Lu iD, Mayu Morita, Tyler S Yeager iD, Yunpeng Lyu, Sophia Y Wang, Zhigang Wang, Guang Fan

Diagnostics · 14.02.2024 · 14 (4) · 420

DOI: 10.3390/diagnostics14040420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 14.02.2024. Verfasst von Zhengchun Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DeepCyto, LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flow cytometry is a vital diagnostic tool for hematologic and immunologic disorders, but manual analysis is prone to variation and time-consuming. Over the last decade, artificial intelligence (AI) has advanced significantly. In this study, we developed and validated an AI-assisted flow cytometry workflow using 379 clinical cases from 2021, employing a 3-tube, 10-color flow panel with 21 antibodies for primary immunodeficiency diseases and related immunological disorders. The AI software (DeepFlow™, version 2.1.1) is fully automated, reducing analysis time to under 5 min per case. It interacts with hematopatholoists for manual gating adjustments when necessary. Using proprietary multidimensional density–phenotype coupling algorithm, the AI model accurately classifies and enumerates T, B, and NK cells, along with important immune cell subsets, including CD4+ helper T cells, CD8+ cytotoxic T cells, CD3+/CD4−/CD8− double-negative T cells, and class-switched or non-switched B cells. Compared to manual analysis with hematopathologist-determined lymphocyte subset percentages as the gold standard, the AI model exhibited a strong correlation (r > 0.9) across lymphocyte subsets. This study highlights the accuracy and efficiency of AI-assisted flow cytometry in diagnosing immunological disorders in a clinical setting, providing a transformative approach within a concise timeframe.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligenceclinical caseshematopathologymultiparameter flow cytometrypanel for autoimmune lymphoproliferative syndrome

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
  • DeepCyto LLC, West Linn, OR 97068, USA.

ORCID-Profile: Zhengchun Lu, Tyler S Yeager

Förderung

  • DeepCyto, LLC

Zitieren

APA

Lu, Z., Morita, M., Yeager, T. S., Lyu, Y., Wang, S. Y., Wang, Z., & Fan, G. (2024). Validation of Artificial Intelligence (AI)-Assisted Flow Cytometry Analysis for Immunological Disorders. Diagnostics, 14(4), 420. https://doi.org/10.3390/diagnostics14040420

Vancouver

Lu Z, Morita M, Yeager TS, Lyu Y, Wang SY, Wang Z, et al. Validation of Artificial Intelligence (AI)-Assisted Flow Cytometry Analysis for Immunological Disorders. Diagnostics. 2024;14(4):420. doi:10.3390/diagnostics14040420

BibTeX
@article{Lu2024,
  author = {Lu, Zhengchun and Morita, Mayu and Yeager, Tyler S and Lyu, Yunpeng and Wang, Sophia Y and Wang, Zhigang and Fan, Guang},
  title = {Validation of Artificial Intelligence (AI)-Assisted Flow Cytometry Analysis for Immunological Disorders},
  journal = {Diagnostics},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {420},
  doi = {10.3390/diagnostics14040420}
}
Kostenlos starten →